Center for Scientific Review; Notice of Closed Meetings, 37684-37685 [2020-13413]
Download as PDF
<![CDATA[
37684
Federal Register / Vol. 85, No. 121 / Tuesday, June 23, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
acquisition threshold (currently
$150,000) over the period of
performance. An applicant may review
and comment on any information about
itself that a Federal awarding agency
previously entered. The IHS will
consider any comments by the
applicant, in addition to other
information in FAPIIS in making a
judgment about the applicant’s integrity,
business ethics, and record of
performance under Federal awards
when completing the review of risk
posed by applicants as described in 45
CFR 75.205.
As required by 45 CFR part 75,
appendix XII of the Uniform Guidance,
non-Federal entities (NFEs) are required
to disclose in FAPIIS any information
about criminal, civil, and administrative
proceedings, and/or affirm that there is
no new information to provide. This
applies to NFEs that receive Federal
awards (currently active grants,
cooperative agreements, and
procurement contracts) greater than
$10,000,000 for any period of time
during the period of performance of an
award/project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the
Uniform Guidance, and the HHS
implementing regulations at 45 CFR part
75, the IHS must require a non-Federal
entity or an applicant for a Federal
award to disclose, in a timely manner,
in writing to the IHS or pass-through
entity all violations of Federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award.
Submission is required for all
applicants and recipients, in writing, to
the IHS and to the HHS Office of
Inspector General all information
related to violations of Federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and Human
Services, Indian Health Service,
Division of Grants Management, ATTN:
Paul Gettys, Acting Director, 5600
Fishers Lane, Mail Stop: 09E70,
Rockville, MD 20857, (Include
‘‘Mandatory Grant Disclosures’’ in
subject line), Office: (301) 443–5204,
Fax: (301) 594–0899, Email:
Paul.Gettys@ihs.gov and U.S.
Department of Health and Human
Services, Office of Inspector General,
ATTN: Mandatory Grant Disclosures,
Intake Coordinator, 330 Independence
Avenue SW, Cohen Building, Room
5527, Washington, DC 20201, URL:
https://oig.hhs.gov/fraud/report-fraud/,
(Include ‘‘Mandatory Grant Disclosures’’
VerDate Sep<11>2014
17:17 Jun 22, 2020
Jkt 250001
in subject line), Fax: (202) 205–0604
(Include ‘‘Mandatory Grant Disclosures’’
in subject line) or Email:
MandatoryGranteeDisclosures@
oig.hhs.gov.
Failure to make required disclosures
can result in any of the remedies
described in 45 CFR 75.371 Remedies
for noncompliance, including
suspension or debarment (See 2 CFR
parts 180 & 376).
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to: Verly
Fairbanks, Management/Program
Analyst, Office of Direct Service and
Contracting Tribes, Indian Health
Service, 5600 Fishers Lane, Mail Stop:
08E17, Rockville, MD 20857,
Telephone: (301) 443–1104, Email:
Verly.Fairbanks@ihs.gov.
2. Questions on grants management
and fiscal matters may be directed to:
Mr. Andrew Diggs, Grants Management
Specialist, Indian Health Service,
Division of Grants Management, 5600
Fishers Lane, Mail Stop: 09E70,
Rockville, MD 20857, Phone: (301) 443–
2241, Fax: (301) 594–0899, Email:
Andrew.Diggs@ihs.gov.
3. Questions on systems matters may
be directed to: Mr. Paul Gettys, Acting
Director, Indian Health Service,
Division of Grants Management, 5600
Fishers Lane, Mail Stop: 09E70,
Rockville, MD 20857, Phone: (301) 443–
2114; or the DGM main line (301) 443–
5204, Fax: (301) 594–0899, E-Mail:
Paul.Gettys@ihs.gov.
VIII. Other Information
The Public Health Service strongly
encourages all grant, cooperative
agreement and contract recipients to
provide a smoke-free workplace and
promote the non-use of all tobacco
products. In addition, Public Law 103–
227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities
(or in some cases, any portion of the
facility) in which regular or routine
education, library, day care, health care,
or early childhood development
services are provided to children. This
is consistent with the HHS mission to
protect and advance the physical and
mental health of the American people.
Michael D. Weahkee,
RADM, Assistant Surgeon General, U.S.
Public Health Service Director, Indian Health
Service.
[FR Doc. 2020–13470 Filed 6–22–20; 8:45 am]
BILLING CODE 4165–16–P
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Immunity of Transplantation,
Tolerance and Tumors.
Date: July 13, 2020.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Betty Hayden, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892, (301) 435–
1223, haydenb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Clinical Trial
Readiness (R21) and Phased Clinical Trials
(R61/R33) for Investigations of Co-occurring
Conditions across the Lifespan to Understand
Down syndromE (INCLUDE).
Date: July 16, 2020.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Katherine Colona Morasch,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7848, Bethesda, MD 20892, (301) 594–
9147, moraschkc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Oncology.
Date: July 20–21, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific
Review Officer, Center for Scientific Review,
E:\FR\FM\23JNN1.SGM
23JNN1
Federal Register / Vol. 85, No. 121 / Tuesday, June 23, 2020 / Notices
National Institutes of Health, 6701 Rockledge
Drive, Rm. 4196, MSC 7848, Bethesda, MD
20892, (301) 827–5902, caojn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR Panel:
Research on Psychosocial Factors of Social
Connectedness and Isolation on Health, WellBeing, Illness and Recovery.
Date: July 20–21, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Andrea B Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Behavioral Genetics, Cancer
Genetics, Epidemiology and Computational
Biology.
Date: July 20, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Fungai Chanetsa, MPH,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, (301) 408–
9436, fungai.chanetsa@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Development and
Testing of New Technologies and
Bioengineering Solutions for the
Advancement of Cell Replacement Therapies
for Type 1 Diabetes (R43/R44 Clinical Trial
Not Allowed).
Date: July 28, 2020.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–2242,
jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 17, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–13415 Filed 6–22–20; 8:45 am]
BILLING CODE 4140–01–P
Dated: June 17, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–13413 Filed 6–22–20; 8:45 am]
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
jbell on DSKJLSW7X2PROD with NOTICES
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Sep<11>2014
17:17 Jun 22, 2020
Jkt 250001
National Institutes of Health
37685
Special Emphasis Panel; A trial of
transplanting Hepatitis C-viremic kidneys
into Hepatitis C-Negative kidney recipients
(THINKER–NEXT).
Date: July 22, 2020.
Time: 1:00 p.m. to 2:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Clinical, imaging,
and endoscopic outcomes of children newly
diagnosed with Crohn’s disease. (U34).
Date: July 31, 2020.
Time: 3:00 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 17, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–13414 Filed 6–22–20; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Motor Function,
Speech and Rehabilitation Study
Section, June 29, 2020, 08:00 a.m. to
June 30, 2020, 05:00 p.m., National
Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD, 20892
which was published in the Federal
Register on June 02, 2020, 85 FR 33690.
This notice is being amended to
change the meeting start time from
08:00 a.m. to 05:00 p.m. to 09:00 a.m.
E:\FR\FM\23JNN1.SGM
23JNN1
]]>Agencies
[Federal Register Volume 85, Number 121 (Tuesday, June 23, 2020)]
[Notices]
[Pages 37684-37685]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13413]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Conflict: Immunity of Transplantation, Tolerance and
Tumors.
Date: July 13, 2020.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Betty Hayden, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4206, MSC 7812, Bethesda, MD 20892, (301) 435-
1223, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel Clinical Trial Readiness (R21) and Phased Clinical Trials
(R61/R33) for Investigations of Co-occurring Conditions across the
Lifespan to Understand Down syndromE (INCLUDE).
Date: July 16, 2020.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Katherine Colona Morasch, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170, MSC 7848, Bethesda, MD
20892, (301) 594-9147, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowships: Oncology.
Date: July 20-21, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific Review Officer, Center
for Scientific Review,
[[Page 37685]]
National Institutes of Health, 6701 Rockledge Drive, Rm. 4196, MSC
7848, Bethesda, MD 20892, (301) 827-5902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel PAR Panel: Research on Psychosocial Factors of Social
Connectedness and Isolation on Health, Well-Being, Illness and
Recovery.
Date: July 20-21, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Andrea B Kelly, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD
20892, (301) 455-1761, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Conflict: Behavioral Genetics, Cancer Genetics,
Epidemiology and Computational Biology.
Date: July 20, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Fungai Chanetsa, MPH, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135, MSC 7770, Bethesda, MD
20892, (301) 408-9436, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 17, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-13413 Filed 6-22-20; 8:45 am]
BILLING CODE 4140-01-P
